Open Access iconOpen Access

ARTICLE

Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G2 Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells

Makoto Akiyama*†, Yoshihiro Sowa*, Tomoyuki Taniguchi*, Motoki Watanabe*, Shingo Yogosawa, Jo Kitawaki,Toshiyuki Sakai*

* Department of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan
† Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan
‡ Department of Public Health and Environmental Medicine, The Jikei University School of Medicine, Nishi-Shimbashi, Minato-ku, Tokyo, Japan

TSP_OR_96504017.pdf

  • 62

    View

  • 50

    Download

  • 0

    Like

Share Link